DGAP-News: STRATEC Annual General Meeting resolves dividend payment amounting to EUR 0.70 per share


DGAP-News: STRATEC Biomedical AG / Key word(s): AGM/EGM
STRATEC Annual General Meeting resolves dividend payment amounting to
EUR 0.70 per share

22.05.2015 / 20:27

---------------------------------------------------------------------

STRATEC Annual General Meeting resolves dividend payment amounting to EUR
0.70 per share

Birkenfeld, May 22, 2015

The Shareholders of STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard,
TecDAX) approved all of the agenda items put to the vote at today's Annual
General Meeting in Pforzheim with the necessary majorities in each case.
The shareholders present represented 72.85% of the company's share capital.

As proposed, STRATEC will distribute a dividend of EUR 0.70 per share to
its shareholders for the 2014 financial year (previous year: EUR 0.60). The
distribution total amounts to EUR 8.2 million and will be paid to
shareholders via their depository banks on May 26, 2015. The dividend has
thus been increased for the eleventh year in succession since the
initiation of dividend payments in 2004.

Furthermore, Ebner Stolz GmbH & Co. KG, Stuttgart, was elected as auditor
for the 2015 financial year. It was also decided to convert the company's
shares from bearer to registered shares. This conversion is due to be
implemented in the second half of 2015.

The Annual General Meeting also once again approved the creation of
authorized and conditional capitals, an authorization to acquire and sell
own shares, and various amendments to the Articles of Association.

Further information about our Annual General Meeting can be found on the
company's website at www.stratec.com/agm, where details of voting results
have also been published.

About STRATEC
STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully
automated analyzer systems for its partners in the fields of clinical
diagnostics and biotechnology. These partners market such systems, in
general together with their own reagents, as system solutions to
laboratories, blood banks and research institutes around the world. The
company develops its products on the basis of its own patented
technologies.
Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard
segment of the Frankfurt Stock Exchange and are listed in the TecDAX select
index of the German Stock Exchange.

Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Investor Relations
Gewerbestr. 37, 
75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
ir@stratec.com
www.stratec.com



---------------------------------------------------------------------

22.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                     
Company:     STRATEC Biomedical AG                                       
             Gewerbestr. 37                                              
             75217 Birkenfeld                                            
             Germany                                                     
Phone:       +49 (0)7082 7916 0                                          
Fax:         +49 (0)7082 7916 999                                        
E-mail:      info@stratec.com                                            
Internet:    www.stratec.com                                             
ISIN:        DE0007289001                                                
WKN:         728900                                                      
Indices:     TecDAX                                                      
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated   
             Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
361391 22.05.2015